SMILES:
CN1C=C(C=N1)NC2=NC=CC(=N2)N3CC4CCC(C3)N4C(=O)C5CC5(F)F
Chemical Structure
Check the
Brepocitinib (PF-06700841)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | [(1S)-2,2-difluorocyclopropyl]-[(1R,5S)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone | |
|---|---|---|
| CAS Number | 1883299-62-4 | |
| Molecular Formula |
C18H21F2N7O |
|
| Molecular Weight (MW) | 389.40 | |
| SMILES | CN1C=C(C=N1)NC2=NC=CC(=N2)N3CC4CCC(C3)N4C(=O)C5CC5(F)F | |
| InChIKey | BUWBRTXGQRBBHG-MJBXVCDLSA-N |
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
78 mg/mL
(200.3 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 78 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Brepocitinib (PF-06700841) Clinical Trials
- Brepocitinib (PF-06700841) Solubility in DMSO
- Brepocitinib (PF-06700841) Stock Solution
- Brepocitinib (PF-06700841) Storage
- Brepocitinib (PF-06700841) Stability
- Brepocitinib (PF-06700841) Molecular Weight
- Brepocitinib (PF-06700841) CAS Number
- Brepocitinib (PF-06700841) Chemical Structure (2D and 3D)
- Brepocitinib (PF-06700841) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.